BLCM — Bellicum Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Bellicum Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	93	91	35.5	46.2	21.8
Net Total Accounts Receivable
Net Total Receivables	0.909	0.303	0.002	0.205	0
Prepaid Expenses
Total Other Current Assets
Total Current Assets	95.3	112	39.4	49.1	23.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	20.9	3.57	0.834	0.012	0.022
Long Term Investments
Other Long Term Assets
Total Assets	122	116	40.6	49.1	23.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15.8	94.4	24.7	6.71	3.77
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	53	121	25	6.71	3.77
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	68.5	-4.75	15.5	42.4	20.1
Total Liabilities & Shareholders' Equity	122	116	40.6	49.1	23.8
Total Common Shares Outstanding
Total Preferred Shares Outstanding